120 related articles for article (PubMed ID: 29684755)
21. Brief Report: Interleukin-38 Exerts Antiinflammatory Functions and Is Associated With Disease Activity in Systemic Lupus Erythematosus.
Rudloff I; Godsell J; Nold-Petry CA; Harris J; Hoi A; Morand EF; Nold MF
Arthritis Rheumatol; 2015 Dec; 67(12):3219-25. PubMed ID: 26314375
[TBL] [Abstract][Full Text] [Related]
22. Decreased production of TGF-beta by lymphocytes from patients with systemic lupus erythematosus.
Ohtsuka K; Gray JD; Stimmler MM; Toro B; Horwitz DA
J Immunol; 1998 Mar; 160(5):2539-45. PubMed ID: 9498800
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-21 is increased in active systemic lupus erythematosus patients and contributes to the generation of plasma B cells.
Nakou M; Papadimitraki ED; Fanouriakis A; Bertsias GK; Choulaki C; Goulidaki N; Sidiropoulos P; Boumpas DT
Clin Exp Rheumatol; 2013; 31(2):172-9. PubMed ID: 23137515
[TBL] [Abstract][Full Text] [Related]
24. Activation of transforming growth factor-beta1 and early atherosclerosis in systemic lupus erythematosus.
Jackson M; Ahmad Y; Bruce IN; Coupes B; Brenchley PE
Arthritis Res Ther; 2006; 8(3):R81. PubMed ID: 16646981
[TBL] [Abstract][Full Text] [Related]
25. Decreased SAP Expression in T Cells from Patients with Systemic Lupus Erythematosus Contributes to Early Signaling Abnormalities and Reduced IL-2 Production.
Karampetsou MP; Comte D; Kis-Toth K; Terhorst C; Kyttaris VC; Tsokos GC
J Immunol; 2016 Jun; 196(12):4915-24. PubMed ID: 27183584
[TBL] [Abstract][Full Text] [Related]
26. Smad2 and Smad3 are redundantly essential for the suppression of iNOS synthesis in macrophages by regulating IRF3 and STAT1 pathways.
Sugiyama Y; Kakoi K; Kimura A; Takada I; Kashiwagi I; Wakabayashi Y; Morita R; Nomura M; Yoshimura A
Int Immunol; 2012 Apr; 24(4):253-65. PubMed ID: 22331441
[TBL] [Abstract][Full Text] [Related]
27. Pluripotency gene expression and growth control in cultures of peripheral blood monocytes during their conversion into programmable cells of monocytic origin (PCMO): evidence for a regulatory role of autocrine activin and TGF-β.
Ungefroren H; Hyder A; Hinz H; Groth S; Lange H; El-Sayed KM; Ehnert S; Nüssler AK; Fändrich F; Gieseler F
PLoS One; 2015; 10(2):e0118097. PubMed ID: 25707005
[TBL] [Abstract][Full Text] [Related]
28. Altered regulation of IL-2 production in systemic lupus erythematosus: an evolving paradigm.
Kammer GM
J Clin Invest; 2005 Apr; 115(4):836-40. PubMed ID: 15841173
[TBL] [Abstract][Full Text] [Related]
29. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of microRNA-155 increases IL-21 mediated STAT3 signaling and IL-21 production in systemic lupus erythematosus.
Rasmussen TK; Andersen T; Bak RO; Yiu G; Sørensen CM; Stengaard-Pedersen K; Mikkelsen JG; Utz PJ; Holm CK; Deleuran B
Arthritis Res Ther; 2015 Jun; 17(1):154. PubMed ID: 26055806
[TBL] [Abstract][Full Text] [Related]
31. Signs of impaired immunoregulation and enhanced effector T-cell responses in the primary antiphospholipid syndrome.
Jakiela B; Iwaniec T; Plutecka H; Celinska-Lowenhoff M; Dziedzina S; Musial J
Lupus; 2016 Apr; 25(4):389-98. PubMed ID: 26657472
[TBL] [Abstract][Full Text] [Related]
32. Levels of transforming growth factor-beta are low in systemic lupus erythematosus patients with active disease.
Becker-Merok A; Eilertsen GØ; Nossent JC
J Rheumatol; 2010 Oct; 37(10):2039-45. PubMed ID: 20682675
[TBL] [Abstract][Full Text] [Related]
33. Disturbance in Serum Levels of IL-17 and TGF-β1 and in Gene Expression of ROR-γt and FOX-P3 Is Associated with Pathogenicity of Systematic Lupus Erythematosus.
Ali HN; Alubaidi GT; Gorial FI; Jasim IA
Prague Med Rep; 2022; 123(3):166-180. PubMed ID: 36107445
[TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways.
Park JI; Lee MG; Cho K; Park BJ; Chae KS; Byun DS; Ryu BK; Park YK; Chi SG
Oncogene; 2003 Jul; 22(28):4314-32. PubMed ID: 12853969
[TBL] [Abstract][Full Text] [Related]
35. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease.
Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V
Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226
[TBL] [Abstract][Full Text] [Related]
36. Single nucleotide polymorphism T869C of transforming growth factor-beta 1 gene and systemic lupus erythematosus: association with disease susceptibility and lupus nephritis.
Sayed SK; Galal SH; Herdan OM; Mahran AM
Egypt J Immunol; 2014; 21(2):9-21. PubMed ID: 25812349
[TBL] [Abstract][Full Text] [Related]
37. B7/BB1 provides an important costimulatory signal for CD3-mediated T lymphocyte proliferation in patients with systemic lupus erythematosus (SLE).
Sfikakis PP; Oglesby R; Sfikakis P; Tsokos GC
Clin Exp Immunol; 1994 Apr; 96(1):8-14. PubMed ID: 7512010
[TBL] [Abstract][Full Text] [Related]
38. The immune suppressive function of transforming growth factor-β (TGF-β) in human diseases.
Sheng J; Chen W; Zhu HJ
Growth Factors; 2015 Apr; 33(2):92-101. PubMed ID: 25714613
[TBL] [Abstract][Full Text] [Related]
39. Responsiveness of systemic lupus erythematosus T cells to signals provided through LCA T200 (CD45) and T1 (CD5) antigens.
Martorell J; Font J; Rojo I; Vilella R; Ingelmo M; Vives J
Clin Exp Immunol; 1989 Nov; 78(2):172-6. PubMed ID: 12412744
[TBL] [Abstract][Full Text] [Related]
40. Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus.
von Spee-Mayer C; Siegert E; Abdirama D; Rose A; Klaus A; Alexander T; Enghard P; Sawitzki B; Hiepe F; Radbruch A; Burmester GR; Riemekasten G; Humrich JY
Ann Rheum Dis; 2016 Jul; 75(7):1407-15. PubMed ID: 26324847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
